A Comparison of Insulin Doses for the Treatment of Hyperkalemia in Patients with Renal Insufficiency.
Pharmacotherapy
; 37(12): 1516-1522, 2017 12.
Article
en En
| MEDLINE
| ID: mdl-28976587
ABSTRACT
STUDY OBJECTIVE:
To compare the safety and efficacy of 5 units versus 10 units of insulin for the treatment of hyperkalemia in patients with renal insufficiency.DESIGN:
Retrospective cohort study.SETTING:
Large academic medical center emergency department. PATIENTS Between March 1, 2008, and February 29, 2016, 675 patients met the inclusion criteria of age 18 years and older, serum potassium greater than 5 mEq/L, renal insufficiency, 5 units or 10 units of intravenous regular insulin administered in the emergency department, and blood glucose documented within 5 hours after insulin administration. Of these patients, 133 (19.7%) received 5 units of insulin and 542 (80.3%) received 10 units of insulin. MEASUREMENTS ANDRESULTS:
The primary outcome was incidence of hypoglycemia (blood glucose < 70 mg/dl). Secondary outcomes were incidence of severe hypoglycemia (blood glucose < 40 mg/dl) and change in serum potassium after insulin therapy. Hypoglycemia occurred in 26 of 133 patients receiving 5 units of insulin (19.5%) and in 155 of 542 patients receiving 10 units (28.6%) (difference = -9.1%, 95% confidence interval [CI] -16.8% to -1.3%). Severe hypoglycemia occurred in 4 of 133 patients (3.0%) and 37 of 542 patients (6.8%) receiving insulin 5 units and 10 units, respectively (difference = -3.8%, 95% CI -7.4% to 0%). Change in serum potassium was similar between groups (-1.0 ± 0.8 vs -1.0 ± 0.7 mEq/L, difference = 0, 95% CI -0.1 to 0.1).CONCLUSION:
In patients with renal insufficiency and hyperkalemia, 5 units of insulin reduced serum potassium to the same extent as 10 units of insulin but with a lower rate of hypoglycemia. Further controlled studies are needed to confirm these findings.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Insuficiencia Renal
/
Hiperpotasemia
/
Insulina
Tipo de estudio:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Pharmacotherapy
Año:
2017
Tipo del documento:
Article